Kymera Therapeutics (KYMR) Fair Value & DCF
KYMR$134.84-1.80 -1.32%
Market cap$11.51BEnterprise value$11.34BRevenue (TTM)$102.22MMarket positionTop 25%
Score
39
Bearish
Value
25
Quality
29
Growth
64
Kymera Therapeutics, Inc. (KYMR) trades at $134.84 on $11.51B of equity value, with a trailing P/E of -37.53. Fair value on Stocklytics blends discounted cash flow and an earnings-based cross-check when the saved model is on file. The price and ratio here are from the live quote.